XML 48 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Net Loss Per Share (Tables)
12 Months Ended
Dec. 31, 2025
Net Loss Per Share [Abstract]  
Schedule of Anti-dilutive Shares

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2025 and 2024 are as follows:

 

   Year ended
December 31,
2025
(Shares)
   Year ended
December 31,
2024
(Shares)
 
Convertible debt   633,829,229    40,731,757 
Stock options   1,780,001    1,513,335 
Warrants to purchase shares of common stock   380,627,934    22,011,614 
    1,016,237,164    64,256,706